---
figid: PMC5821903__rccm.201703-0615CI_f1
figtitle: Schematic overview of anabolic and catabolic signaling in skeletal muscle
organisms:
- Homo sapiens
pmcid: PMC5821903
filename: rccm.201703-0615CI_f1.jpg
figlink: /pmc/articles/PMC5821903/figure/fig1/
number: F1
caption: Schematic overview of anabolic and catabolic signaling in skeletal muscle.
  A number of underlying mechanisms contributing to imbalance between muscle protein
  synthesis and protein breakdown have been implicated in limb muscle mass loss in
  patients with chronic obstructive pulmonary disease (COPD) (, , –). The ubiquitin
  proteasome pathway is a major driver of muscle proteolysis and includes the forkhead
  box O (FOXO) transcription factor–regulated muscle-specific E3 ubiquitin ligases
  muscle ring finger protein 1 E3-ligase (MuRF-1) and atrogin-1 (, ). The autophagy–lysosomal
  pathway is another contributing mechanism to protein degradation in response to
  atrophic stimuli in the setting of COPD (). Conversely, the GH–IGF-1–AKT–mTOR axis
  positively affects protein synthesis and may attenuate protein breakdown via AKT-mediated
  negative regulation of FOXO. ActRIIB = activin receptor type IIB; AKT = protein
  kinase B; AR = androgen receptor; GH = growth hormone; GHR = growth hormone receptor;
  IGF-1 = insulin-like growth factor 1; IGF1R = insulin-like growth factor 1 receptor;
  IKK = IκB kinase; IR = insulin receptor; JAK2 = janus kinase 2; JNK = Jun N-terminal
  kinase; mTOR = mammalian target of rapamycin; MyoD = myogenic differentiation 1;
  NFκB = nuclear factor-κB; P38 = p38 mitogen-activated protein kinase; PI3K = phosphatidylinositol-4,5-bisphosphate
  3-kinase; ROS = reactive oxygen species; STAT = signal transducer and activator
  of transcription.
papertitle: Deterioration of Limb Muscle Function during Acute Exacerbation of Chronic
  Obstructive Pulmonary Disease.
reftext: Raolat M. Abdulai, et al. Am J Respir Crit Care Med. 2018 Feb 15;197(4):433-449.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9595851
figid_alias: PMC5821903__F1
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC5821903__F1
ndex: ea2be56b-dedf-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5821903__rccm.201703-0615CI_f1.html
  '@type': Dataset
  description: Schematic overview of anabolic and catabolic signaling in skeletal
    muscle. A number of underlying mechanisms contributing to imbalance between muscle
    protein synthesis and protein breakdown have been implicated in limb muscle mass
    loss in patients with chronic obstructive pulmonary disease (COPD) (, , –). The
    ubiquitin proteasome pathway is a major driver of muscle proteolysis and includes
    the forkhead box O (FOXO) transcription factor–regulated muscle-specific E3 ubiquitin
    ligases muscle ring finger protein 1 E3-ligase (MuRF-1) and atrogin-1 (, ). The
    autophagy–lysosomal pathway is another contributing mechanism to protein degradation
    in response to atrophic stimuli in the setting of COPD (). Conversely, the GH–IGF-1–AKT–mTOR
    axis positively affects protein synthesis and may attenuate protein breakdown
    via AKT-mediated negative regulation of FOXO. ActRIIB = activin receptor type
    IIB; AKT = protein kinase B; AR = androgen receptor; GH = growth hormone; GHR = growth
    hormone receptor; IGF-1 = insulin-like growth factor 1; IGF1R = insulin-like growth
    factor 1 receptor; IKK = IκB kinase; IR = insulin receptor; JAK2 = janus kinase
    2; JNK = Jun N-terminal kinase; mTOR = mammalian target of rapamycin; MyoD = myogenic
    differentiation 1; NFκB = nuclear factor-κB; P38 = p38 mitogen-activated protein
    kinase; PI3K = phosphatidylinositol-4,5-bisphosphate 3-kinase; ROS = reactive
    oxygen species; STAT = signal transducer and activator of transcription.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - INHBA
  - INHBB
  - IGF1
  - ACVR2B
  - IGF1R
  - GHR
  - CHUK
  - IKBKB
  - IKBKG
  - IKBKE
  - TBK1
  - CRK
  - MAPK14
  - MAPK1
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK8
  - MAPK9
  - MAPK10
  - SMAD2
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - JAK2
  - AKT1
  - AKT2
  - AKT3
  - FOXO1
  - FOXO3
  - FOXO4
  - FOXO6
  - AR
  - PSMA1
  - PSMA2
  - PSMA3
  - PSMA4
  - PSMA5
  - PSMA6
  - PSMA7
  - PSMA8
  - PSMB1
  - PSMB10
  - PSMB2
  - PSMB3
  - PSMB4
  - PSMB5
  - PSMB6
  - PSMB7
  - PSMB8
  - PSMB9
  - PSMC1
  - PSMC2
  - PSMC3
  - PSMC4
  - PSMC5
  - PSMC6
  - PSMD1
  - PSMD10
  - PSMD11
  - PSMD12
  - PSMD13
  - PSMD14
  - PSMD2
  - PSMD3
  - PSMD4
  - PSMD5
  - PSMD6
  - PSMD7
  - PSMD8
  - PSMD9
  - PSME1
  - PSME2
  - PSME3
  - PSMF1
  - SEM1
  - USP5
  - TRIM63
  - MTOR
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - MYOT
  - Myostatin
  - Testosterone
  - Cancer
---
